BIO (BioProtocol) fluctuates 43.7% in 24 hours: Surge in trading volume and synergy with DeSci sector drive movement
Bitget Pulse2026/04/30 13:47Volatility Brief
In the past 24 hours, BIO price rebounded from a low of $0.03218 to a high of $0.04624 and is currently at $0.04004, with a fluctuation range of 43.7%. Trading volume surged to approximately $260 million, more than doubling the normal level, indicating increased capital activity.
Analysis of the Cause of the Volatility
- Abnormal surge in trading volume: In the past 24 hours, there was a 4.1x abnormal buy volume and an overall 2.8x increase in trading volume, driving the price to a rapid rise and testing resistance.
- DeSci/Biotech sector correlation: The market views BIO as a DeSci proxy, and inflows into the sector have been attracted by relaxed peptide regulation and related news (such as the Lilly incident).
Market Views and Outlook
Mainstream community sentiment is cautiously optimistic. Traders are watching the $0.032–$0.034 support level; if it holds and there is a rebound with increased volume, the uptrend may extend to $0.037–$0.040. Conversely, if $0.032 is lost, a pullback to $0.028–$0.030 is possible. Analysts such as Finora AI advise against chasing the rally, recommending entry upon confirmed pullbacks and warning against false breakout risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for information reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BitBox firmware vulnerability fixed as Coldcard’s flaw drains $115M in bitcoin
From the surge in global stock markets and the resilience of gold to arbitrage opportunities in emerging markets, the underlying assumption for this year’s cross-asset trends is that “real interest rates will decline”—but is this really the case?
Goldman Sachs analysis points out that the current cross-asset boom in the stock market, gold, emerging market arbitrage, and narrowing credit spreads essentially shares the same logic: real interest rates are expected to decline soon. However, the U.S. 10-year real yield remains at a relatively high level of around 2.50%, and the key premise has not yet materialized. Goldman Sachs advises not to fight against the arbitrage narrative for now, but to control positions and take cues from the direction of real interest rates as the ultimate basis for judgment.
TACO Returns! Trump Temporarily Delays 50% Tariffs on Canada; $20 Billion Worth of Goods Temporarily Spared from Tariff Storm
U.S. President Donald Trump announced on Tuesday evening that he will postpone by three days the new 50% tariffs on Canadian goods that were scheduled to take effect on Wednesday, stating that the two countries have reached an agreement.
Wintermute: Bitcoin Range Breakout Delayed by ETF Outflows and Miner Selling
